Restricted accessResearch articleFirst published online 2025-9
British Association for Sexual Health and HIV (BASHH) UK national guideline for the use of doxycycline post-exposure prophylaxis (DoxyPEP) for the prevention of syphilis,2025
This guideline provides evidence-based recommendations for the use of doxycycline post exposure prophylaxis (doxyPEP) for the prevention of syphilis. DoxyPEP should be part of a comprehensive approach to the prevention of STIs, along with condom use, appropriate HIV prevention interventions, vaccination, STI testing, treatment and management, and appropriate risk reduction advice and psychological interventions if indicated.
MolinaJMCharreauIChidiacC, et al.Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis2018; 18(3): 308–317.
2.
MolinaJMBercotBAssoumouL, et al.Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design. Lancet Infect Dis2024; 24: 1093–1104.
3.
LuetkemeyerAFDonnellDDombrowskiJC, et al.Postexposure doxycycline to prevent bacterial sexually transmitted infections. N Engl J Med2023; 388(14): 1296–1306.
4.
StewartJOwareKDonnellD, et al.Doxycycline prophylaxis to prevent sexually transmitted infections in women. N Engl J Med2023; 389(25): 2331–2340.
5.
SokollPRMigliavacaCBDöringS, et al.Efficacy of postexposure prophylaxis with doxycycline (Doxy-PEP) in reducing sexually transmitted infections: a systematic review and meta-analysis. Sex Transm Infect2025; 101(1): 59–67.
6.
BercotBCharreauIRousseauC, et al.High prevalence and high rate of antibiotic resistance of mycoplasma genitalium infections in men who have sex with men: a substudy of the ANRS IPERGAY pre-exposure prophylaxis trial. Clin Infect Dis2021; 73(7): e2127–e2133.
7.
LuetkemeyerAFDonnellDCohenSE, et al.Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension. Lancet Infect Dis2025. DOI: 10.1016/s1473-3099(25)00085-4.
8.
ScottHRomanJSpinelliMA, et al.Doxycycline PEP: high uptake and significant decline in STIs after clinical implementation. In: Conference on retrovirsuses and opportunistic infections (CROI), 2024.
9.
SankaranMGliddenDVKohnRP, et al.Doxy-PEP associated with declines in Chlamydia and Syphilis in MSM and trans women in San Francisco. In: Conference on retrovirsuses and opportunistic infections (CROI), 2024.
10.
TraegerMWLeydenWAVolkJE, et al.Doxycycline postexposure prophylaxis and bacterial sexually transmitted infections among individuals using HIV preexposure prophylaxis. JAMA Intern Med2025; 185: 273–281.
11.
FredericksenRJPerkinsRBrownCE, et al.Doxycycline as postsexual exposure prophylaxis: use, acceptability, and associated sexual health behaviors among a multi-site sample of clinical trial participants. AIDS Patient Care STDS2024; 38(4): 155–167.
12.
DigreKB. Not so benign intracranial hypertension. BMJ2003; 326(7390): 613–614.
ChanPALe BrazidecDLBecasenJS, et al.Safety of longer-term doxycycline use: a systematic review and meta-analysis with implications for bacterial sexually transmitted infection chemoprophylaxis. Sex Transm Dis2023; 50(11): 701–712.
15.
National Institute for Health and Care Excellence. Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing. NICE guideline [NG117]. London: NICE, 2018. [cited 2025 April 3]. Available from: https://www.nice.org.uk/guidance/ng117 (accessed 3 April 2025).
16.
National Institute for Health and Care Excellence. Acne vulgaris: management. NICE guideline [NG198]. London: NICE, 2023. [cited 2025 April 3]. Available from: https://www.nice.org.uk/guidance/ng198 (accessed 3 April 2025).
17.
National Institute for Health and Care Excellence. Urinary tract infection (recurrent): antimicrobial prescribing. NICE guideline [NG112]. London: NICE, 2024. [cited 2025 April 3]. Available from: https://www.nice.org.uk/guidance/ng112
18.
TantaloLCLuetkemeyerALiebermanNAP, et al.In vitro exposure of treponema pallidum to subbactericidal doxycycline did not induce resistance: implications for doxycycline postexposure prophylaxis. J Infect Dis2024; 231: 729–733.
19.
LuetkemeyerADonnellDDombrowskiJC, et al.DoxyPEP and antimicrobial resistance in N. gonorrhoeae, commensal Neisseria and S. aureus. CROI 2023. Washington: Seattle, 2023.
20.
SogeOOThibaultCSCannonCA, et al.Potential impact of doxycycline post-exposure prophylaxis on tetracycline resistance in Neisseria gonorrhoeae and colonization with tetracycline-resistant Staphylococcus aureus and group A Streptococcus. Clin Infect Dis2025: ciaf089. DOI: 10.1093/cid/ciaf089.
21.
VanbaelenTManoharan-BasilSSKenyonC. Doxycycline postexposure prophylaxis could induce cross-resistance to other classes of antimicrobials in Neisseria gonorrhoeae : an in silico analysis. Sex Transm Dis2023; 50(8): 490–493.
22.
GestelsZManoharan-BasilSSKenyonC. Doxycycline post exposure prophylaxis could select for cross-resistance to other antimicrobials in various pathogens: an in silico analysis. Int J STD AIDS2023; 34(13): 962–968.
23.
JensenJSUnemoM. Antimicrobial treatment and resistance in sexually transmitted bacterial infections. Nat Rev Microbiol2024; 22(7): 435–450.
24.
LegiawatiLHalimPAFitrianiM, et al.Microbiomes in acne vulgaris and their susceptibility to antibiotics in Indonesia: a systematic review and meta-analysis. Antibiotics (Basel)2023; 12(1): 145.
25.
NakaseKKoizumiJFukumotoS, et al.Increased prevalence of minocycline-resistant staphylococcus epidermidis with tet(M) by tetracycline use for acne treatment. Microb Drug Resist2022; 28(8): 861–866.
26.
MoonSHRohHSKimYH, et al.Antibiotic resistance of microbial strains isolated from Korean acne patients. J Dermatol2012; 39(10): 833–837.
27.
TanHHGohCLYeoMG, et al.Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore. Ann Acad Med Singap2001; 30(1): 22–25.
28.
BuchekGMendeKTeluK, et al.Travel-associated multidrug-resistant organism acquisition and risk factors among US military personnel. J Travel Med2021; 28(3): taab028.
29.
ArthurJDEcheverriaPShanksGD, et al.A comparative study of gastrointestinal infections in United States soldiers receiving doxycycline or mefloquine for malaria prophylaxis. Am J Trop Med Hyg1990; 43(6): 608–613.
30.
VentoTJColeDWMendeK, et al.Multidrug-resistant gram-negative bacteria colonization of healthy US military personnel in the US and Afghanistan. BMC Infect Dis2013; 13: 68.
MendeKBeckiusMLZeraWC, et al.Lack of doxycycline antimalarial prophylaxis impact on staphylococcus aureus tetracycline resistance. Diagn Microbiol Infect Dis2016; 86(2): 211–220.
33.
BurgenerADGrennanTKnodelS, et al.DoxyPEP impact on the microbiome of men who have sex with men and transgender women on HIV PrEP. In: CROI 2025, San Francisco, California, 2025.
34.
CarpenterLMillerSFlynnE, et al.Exposure to doxycycline increases risk of carrying a broad range of enteric antimicrobial resistance determinants in an elderly cohort. J Infect2024; 89(4): 106243.
35.
KangKImamovicLMisiakouMA, et al.Expansion and persistence of antibiotic-specific resistance genes following antibiotic treatment. Gut Microbes2021; 13(1): 1–19.
36.
CheungMKNgRWYLaiCKC, et al.Alterations in faecal microbiome and resistome in Chinese international travellers: a metagenomic analysis. J Travel Med2023; 30(6): taad027.
37.
JavelleEMayetAMillionM, et al.Gut microbiota in military international travelers with doxycycline malaria prophylaxis: towards the risk of a simpson paradox in the human microbiome field. Pathogens2021; 10(8): 1063.
38.
MättöJMaukonenJAlakomiHL, et al.Influence of oral doxycycline therapy on the diversity and antibiotic susceptibility of human intestinal bifidobacterial population. J Appl Microbiol2008; 105(1): 279–289.
39.
JoJ-HHarkinsCPSchwardtNH, et al.Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics. Sci Transl Med2021; 13(625): eabd8077.
40.
ParkS-YKimHSLeeSH, et al.Characterization and analysis of the skin microbiota in acne: impact of systemic antibiotics. J Clin Med2020; 9(1): 168.
41.
SiuJMackenzieBWKlinglerL, et al.Sinonasal and gastrointestinal bacterial composition and abundance are stable after 1 week of once-daily oral antibiotic treatment for chronic rhinosinusitis. Int Forum Allergy Rhinol2021; 11(9): 1355–1366.
42.
WooYRLeeSHChoSH, et al.Characterization and analysis of the skin microbiota in rosacea: impact of systemic antibiotics. J Clin Med2020; 9(1): 185.
43.
SunSNarayananPVickersA, et al.GRASP report: data to August 2024. London: UK Health Security Agency, 2024.
44.
HaalandREFountainJEdwardsTE, et al.Pharmacokinetics of single dose doxycycline in the rectum, vagina, and urethra: implications for prevention of bacterial sexually transmitted infections. EBioMedicine2024; 101: 105037.
45.
Grant A. BASHH position statement on doxycycline use in pregnancy. 2024.
46.
Electronic Medicines Compendium. Doxycycline 100mg capsules - summary of product characteristics (SmPC). UK: Datapharm. [cited 2025 April 3]. Available from: https://www.medicines.org.uk/emc/product/13082/smpc (2021, accessed 3 April 2025).
RaccagniARBruzzesiECastagnaA, et al.Doxycycline postexposure prophylaxis may delay seroconversion in incident syphilis. Sex Transm Infect2024; 100(6): 397.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
